P&G Appoints Joseph Jimenez of Novartis to Board of Directors
16 December 2017 - 9:15AM
Business Wire
The Procter & Gamble Company (NYSE:PG) today announced that
it has appointed Joseph Jimenez, Chief Executive Officer of
Novartis AG, to its Board of Directors, effective March 1,
2018.
This press release features multimedia. View
the full release here:
http://www.businesswire.com/news/home/20171215005849/en/
Joseph Jimenez, Chief Executive Officer
of Novartis AG, was appointed to P&G’s Board of Directors,
effective March 1, 2018. (Photo: Business Wire)
Mr. Jimenez has served as Chief Executive Officer of Novartis
since 2010, managing the company’s diversified healthcare portfolio
of leading businesses in innovative pharmaceuticals, eye care,
generics, consumer health, vaccines, and diagnostics. During his
tenure, Mr. Jimenez focused on leading global businesses, while
divesting non-core divisions. He helped reshape Novartis through a
series of complex transactions worth more than $30 billion in 2015
and put a new operating model in place that allowed Novartis to be
more efficient, sustain its investments in research and
development, and focus resources on customers.
“Joe has a distinguished track record of success in healthcare,
consumer products and international businesses,” said David S.
Taylor, P&G’s Chairman, President and Chief Executive Officer.
“We will deeply benefit from Joe’s experience, expertise and
leadership as we continue to transform P&G.”
“We are fortunate to be able to add Joe Jimenez, a highly
experienced and accomplished leader in the consumer products
industry, to our Board,” said Jim McNerney, P&G’s Lead
Director. “We appreciate the input we have received from
shareholders as we continue to refresh our Board.”
“I’m honored to be appointed to the Board of Directors. P&G
is one of the most respected companies, recognized for its
exemplary consumer focus. I look forward to being part of a strong
team contributing to this great company’s transformation and future
success,” said Mr. Jimenez.
Mr. Jimenez currently serves on the Board of General Motors
Company, and has previously served on the Boards of the
Colgate-Palmolive Company, Speedel HLDG AG, Blue Nile Inc., and
ASTRAZENECA PLC.
About Procter & Gamble
P&G serves consumers around the world with one of the
strongest portfolios of trusted, quality, leadership brands,
including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®,
Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head &
Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®,
Tide®, Vicks®, and Whisper®. The P&G community includes
operations in approximately 70 countries worldwide. Please visit
http://www.pg.com for the latest news and information about P&G
and its brands.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171215005849/en/
P&G Media Contact:Damon Jones,
513-983-0190jones.dd@pg.comorP&G Investor Relations
Contact:John Chevalier,
513-983-9974chevalier.jt@pg.comorNovartis Media Contact:Eric
Althoff, 646-438-4335eric.althoff@novartis.com
Procter and Gamble (NYSE:PG)
Historical Stock Chart
From Apr 2024 to May 2024
Procter and Gamble (NYSE:PG)
Historical Stock Chart
From May 2023 to May 2024